R. Paniagua

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas

A. Balmain, Biyonka Liang, B. Hann, 2019, Journal of Immunotherapy for Cancer.